3Sangtawesin V,Sangtawesin C,Raksasinborisut C,et al.Oral ibuprofan prophylaxis for symptomatic patent ductus arteriosna of prematurity.J Med Assoc Thai,2006,89:314-321.
4Malviya MN,Ohlsson A,Shah SS.Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.Cochrane Database of Systematic Reviews,2008,CD003951.
5El-Khuffash AF,Molloy EJ.Influence of a patent duetus arteriosus on cardiac troponin T levels in preterm infants.J Pediatr,2008,153:350-353.
6Maher KO,Reed H,Cuadrado A,et al.B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children.Pediatrics,2008,121:e1484-1488.
7Cooke L,Steer PA,Woodgate PG.Indomethacin for asymptomatic patent duetus arteriesus in preterm infants.Cochrane Database of Systematic Reviews,2003,CD003745.
8Tschuppert S,Doell C,Arlettaz-Mieth R,et al.The effect of ductal diameter on surgical and medical closure of patent ductus arteriesus in preterm neonates:size matters.J Thorac Cardiovasc Surg,2008,135:78-82.
9Mosaili R,AIFaleh KM.Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.Cochrane Database of Systematic Reviews,2008,CDOO6181.
10Shah SS,Ohlsson A.Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.Cochrane Database of Systematic Reviews,2006,CD004213.
2Ohlsson A,Walia R,Shah S.Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants [ J ].Cochrane Datebase Syst Rev,2003,(2):3481.
3van Overmeire B,Smets K,Lecoutere D,et al.A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus[ J ].N Engl J Med,2000,343:674-681.
4Raju NV,Bharadwaj RA,Thonas R,et al.Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia:a pilot study[J].J Perinatol,2000,1:13-16.
5van Overmeire B,Touw D,Schepens PJC,et al.Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus[J ].Clin Pharmacol Ther,2001,70:336-343.
6Sharma PK,Garg Sk,Narang A.Pharmacokinetics of oral ibuprofen in premature infants[ J ].J Clin Pharmacol,2003,43 (9):968-973.
7Heyman E,Morag I,Batash D,et al.Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns:a pilot study[ J ].Pediatrics,2003,112 (3):354-358.
8Itabashi K,Ohno T,Nishida H.Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin[ J ].J Pediatr,2003,143(2):203-207.
9Thomas RL,Parker GC,van Overmeire B.A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus [J].Eur J Pediatr,2005,164(3):135-140.
10Gournay V,Savagner C,Thiriez G,et al.Pulmonary hypertension after ibuprofen prophylaxis in very low preterm infants [ J ].Lancet,2002,359:1486-1488.
8Kabra N S,Schmidt B,Roberts R S,et al.Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants:Results from the trial of indomethacin prophylaxis in preterms[J].J Pediatr,2007,150(8):229-234.
9Herrera C,Holberton J,Davis P.Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in pretert infants[J/CD].Cochrance Database Syst Rev,2007,2:CD003480.
10Shah S S,Ohlsson A.Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weigjt infants[J/CD].Cochrance Database Syst Rev,2006,25:CD004213.
